Literature DB >> 8933647

Effects of oral administration of erythritol on patients with diabetes.

M Ishikawa1, M Miyashita, Y Kawashima, T Nakamura, N Saitou, J Modderman.   

Abstract

Erythritol (20 g in solution) was administered orally in a single-dose to 5 patients with diabetes. Serum erythritol levels reached a peak 1 hr after administration and then declined rapidly. Total urinary excretion was 82.0 +/- 3.7% within 24 hr and 88.5 +/- 3.3% within 72 hr. Serum glucose and insulin levels remained unchanged until a meal was taken (3 hr after erythritol administration) and then increased. Free fatty acids and 3-hydroxybutyric acid levels increased after erythritol administration but dropped after ingestion of food. In a separate clinical trial, erythritol (20 g) was administered orally daily for 14 days to 11 patients with diabetes. Mean serum glucose and hemoglobin A1c levels decreased over the time period. Indices of renal function-blood urea nitrogen, creatinine, and beta 2-microglobulin-did not change significantly. The single dose study suggests that erythritol exerts no significant effects on the metabolism of diabetic patients. Two-week daily administration of erythritol had no adverse effect on blood glucose control.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8933647     DOI: 10.1006/rtph.1996.0112

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  10 in total

1.  Erythritol reduces small intestinal glucose absorption, increases muscle glucose uptake, improves glucose metabolic enzymes activities and increases expression of Glut-4 and IRS-1 in type 2 diabetic rats.

Authors:  Chika Ifeanyi Chukwuma; Ramgopal Mopuri; Savania Nagiah; Anil Amichund Chuturgoon; Md Shahidul Islam
Journal:  Eur J Nutr       Date:  2017-08-02       Impact factor: 5.614

2.  Does Plasmodium falciparum have an Achilles' heel?

Authors:  Liao Y Chen
Journal:  Malar Chemother Control Elimin       Date:  2014-04-05

3.  Gastrointestinal tolerance of erythritol-containing beverage in young children: a double-blind, randomised controlled trial.

Authors:  E Jacqz-Aigrain; B Kassai; C Cornu; J-M Cazaubiel; B Housez; M Cazaubiel; J-M Prével; M Bell; A Boileau; P de Cock
Journal:  Eur J Clin Nutr       Date:  2015-03-06       Impact factor: 4.016

4.  Unexpected roles for ADH1 and SORD in catalyzing the final step of erythritol biosynthesis.

Authors:  Lisa Schlicker; Doletha M E Szebenyi; Semira R Ortiz; Alexander Heinz; Karsten Hiller; Martha S Field
Journal:  J Biol Chem       Date:  2019-09-11       Impact factor: 5.157

Review 5.  Suitability of sugar alcohols as antidiabetic supplements: A review.

Authors:  Nontokozo Z Msomi; Ochuko L Erukainure; Md Shahidul Islam
Journal:  J Food Drug Anal       Date:  2021-03-15       Impact factor: 6.157

Review 6.  Erythritol Is More Effective Than Xylitol and Sorbitol in Managing Oral Health Endpoints.

Authors:  Peter de Cock; Kauko Mäkinen; Eino Honkala; Mare Saag; Elke Kennepohl; Alex Eapen
Journal:  Int J Dent       Date:  2016-08-21

7.  Spontaneous detachment of Streptococcus mutans biofilm by synergistic effect between zwitterion and sugar alcohol.

Authors:  Jong Hyun Lim; Sang-Hun Song; Hyun-Sub Park; Jeong Rae Lee; Sang-Min Lee
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

8.  Effects of Sweeteners on the Gut Microbiota: A Review of Experimental Studies and Clinical Trials.

Authors:  Francisco Javier Ruiz-Ojeda; Julio Plaza-Díaz; Maria Jose Sáez-Lara; Angel Gil
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

9.  Sugar-Free Dark Chocolate Consumption Results in Lower Blood Glucose in Adults With Diabetes.

Authors:  Barbara Oliveira; Kaja Falkenhain; Jonathan P Little
Journal:  Nutr Metab Insights       Date:  2022-02-07

10.  Gastric emptying of solutions containing the natural sweetener erythritol and effects on gut hormone secretion in humans: A pilot dose-ranging study.

Authors:  Bettina K Wölnerhanssen; Jürgen Drewe; Wout Verbeure; Carel W le Roux; Ludmilla Dellatorre-Teixeira; Jens F Rehfeld; Jens J Holst; Bolette Hartmann; Jan Tack; Ralph Peterli; Christoph Beglinger; Anne C Meyer-Gerspach
Journal:  Diabetes Obes Metab       Date:  2021-02-26       Impact factor: 6.577

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.